Sign In
Buy RHHBY
$54.64
-0.630 (-1.14%)
At Close: Jul 31, 2026
Basel, 23 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed positive topline results from the largest trial to date assessing a COVID-19 treatment in infected non-hospitalised patients (
Roche provides update on tominersen programme in manifest Huntington's disease
04:00pm, Monday, 22'nd Mar 2021
Basel, 22 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the decision to discontinue dosing in the Phase III GENERATION HD1 study of tominersen in manifest Huntington's disease (HD).
Roche's (RHHBY) Tecentriq Meets Primary Goal in Lung Cancer Study
02:22pm, Monday, 22'nd Mar 2021
Roche's (RHHBY) Tecentriq meets primary endpoint of disease-free survival at the interim analysis in lung cancer patients.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the Phase III IMpower010 study evaluating Tecentriq® (atezolizu
Investing In Roche Requires Patience For Pipeline To Unfold
03:17pm, Friday, 19'th Mar 2021
I'm long Roche but expect limited stock price appreciation potential for 2021.
Roche launches cobas pure integrated solutions analyser to help simplify operations in small to medium sized labs
02:00am, Wednesday, 17'th Mar 2021
Basel, 17 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of cobas pure integrated solutions in countries accepting the CE mark.3 This new compact analyser combines three
3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy
11:41am, Tuesday, 16'th Mar 2021
Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition o
Roche Annual General Meeting 2021
07:40am, Tuesday, 16'th Mar 2021
Basel, 16 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its shareholders approved all proposals of the Board of Directors at its ordinary Annual General Meeting (AGM). Owing to
Roche launches SARS-CoV-2 variant test to help monitor emerging coronavirus mutations
02:03am, Tuesday, 16'th Mar 2021
Basel, 16 March 2021- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® SARS-CoV-2 Variant Set 1 Test to detect and differentiate mutations found in variants that originated
Basel, 16 March 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new exploratory 2-year longer-term data from Part 2 of SUNFISH, a global placebo-controlled study evaluating Evrysdi™ (risdi
Why GenMark Stock Soared Today
09:30pm, Monday, 15'th Mar 2021
A healthcare titan is acquiring the diagnostic-test maker for a hefty premium.
GenMark Shares Surge After Roche Announces $1.8 Billion Deal for Molecular Test Maker
10:21am, Monday, 15'th Mar 2021
Shares of U.S.-based GenMark were shooting higher on Monday, after Swiss pharmaceutical group Roche said it will buy the California-based company.
Roche (RHHBY) Inks Deal to Acquire GenMark Diagnostics for $1.8B
10:13am, Monday, 15'th Mar 2021
Roche (RHHBY) signs an agreement to acquire GenMark Diagnostics to test a broad range of pathogens using one patient sample. The deal is valued at around $1.8 billion on a fully diluted basis.
Roche to buy U.S. based GenMark Diagnostics for £1.29 billion
06:58am, Monday, 15'th Mar 2021
Roche Holding AG (SWX: RO) said on Monday that it will buy GenMark Diagnostics (NASDAQ: GNMK) for £1.29 billion. The all-cash deal translates to £17.25 per share.
Roche Diagnostics CEO: GenMark deal will further expand global reach
06:29am, Monday, 15'th Mar 2021
Roche Diagnostics CEO Thomas Schinecker discusses the Swiss pharma company's acquisition of GenMark Diagnostics for $1.8 billion.
